Release Date |
|
| Jan 8, 2010 |
Advaxis to Present at the Sidoti Microcap 2010 Investor Conference |
| Jan 22, 2010 |
Advaxis Issued New Intellectual Property Patent |
| Jan 27, 2010 |
Advaxis Receives $278,978 in Non-Dilutive Tax Credit Sale |
| Feb 1, 2010 |
Advaxis Chairman/CEO Thomas A. Moore Interviewed |
| Feb 19, 2010 |
Advaxis Announces Year End 2009 Results |
| Feb 19, 2010 |
Advaxis Submits 10-K for Fiscal Year 2009 |
| Feb 19, 2010 |
Advaxis Chairman/CEO Thomas A. Moore Issues Statement |
| Mar 4, 2010 |
Advaxis to Present at the French Biotech Tour |
| Mar 8, 2010 |
Advaxis Confirms Long-Term Stability of Listeria-Based Immunotherapeutics' Formulations |
| Mar 10, 2010 |
Equity Research Report on Advaxis Updated |
| Mar 11, 2010 |
Advaxis Develops Room Temperature Formulation of ADXS11-001 |
| Mar 17, 2010 |
Advaxis Schedules Annual General Meeting |
| Mar 18, 2010 |
Advaxis Research in ActA Shows Therapeutic Anti-Cancer Response |
| Mar 22, 2010 |
Advaxis Immunotherapeutic ADXS11-001 Phase 1 Survival Data Extended |
| Mar 25, 2010 |
Advaxis to Present at the 6th Annual Spring Growth Stock Conference |
| Apr 15, 2010 |
Advaxis Initiates Phase II Cervical Dysplasia (CIN) Trial |
| Apr 30, 2010 |
Advaxisâ Live Listeria Prostate Cancer Vaccine Heads for Clinic |
| May 18, 2010 |
Advaxis and the University of Pennsylvania Reach Agreement |
| May 25, 2010 |
Advaxis Invites Shareholders to the 2010 Advaxis Annual General Meeting |
| May 25, 2010 |
Advaxis to Present at the Noble Financial Sixth Annual Equity Growth Conference - Ontrack 2010 |
